Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Systemic Juvenile Idiopathic Arthritis (SJIA)”

Showing 4 of 0 results

Not applicableLooking for participantsNCT07517250
What this trial is testing

A Study on the Use of Canakinumab Among Familial Mediterranean Fever and Still's Disease Patients

Who this might be right for
Familial Mediterranean FeverStill DiseaseSystemic Juvenile Idiopathic Arthritis+1 more
Novartis Pharmaceuticals 160
Not applicableNot Yet RecruitingNCT06718049
What this trial is testing

Role of Interleukin 18 (IL-18) and Interleukin 18 Binding Protein (IL-18BP) in the Diagnostic Work-up of Systemic Juvenile Idiopathic Arthritis and Autoinflammatory Diseases: Possible Biomarkers in the Differential Diagnosis of Other Febrile Diseases

Who this might be right for
Systemic Juvenile Idiopathic Arthritis (sJIA)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 9
Early research (Phase 1)UnknownNCT05027373
What this trial is testing

Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection

Who this might be right for
Systemic Juvenile Idiopathic ArthritisPeriodic Fever Syndrome
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 34
Early research (Phase 1)Study completedNCT01904292
What this trial is testing

Subcutaneously Administered Tocilizumab in Participants With Systemic Juvenile Idiopathic Arthritis

Who this might be right for
Juvenile Idiopathic Arthritis
Hoffmann-La Roche 52

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation